Quarterly report pursuant to Section 13 or 15(d)

Condensed Statement Of Cash Flows

v3.21.2
Condensed Statement Of Cash Flows - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2021
Cash flows from operating activities:    
Net income $ 5,454,687 $ 4,460,101
Adjustments to reconcile net income to net cash used in operating activities:    
Interest income on cash and investments held in Trust Account (5,179) (20,541)
Offering costs allocated to warrant liability   570,496
Change in fair value of warrant liability (6,658,475) (6,496,009)
Changes in operating assets and liabilities:    
Prepaid assets   (929,007)
Accrued costs and expenses   982,690
Due to related party   61,667
Net cash used in operating activities   (1,370,603)
Cash Flows from Investing Activities:    
Investment of cash in Trust Account   (402,500,000)
Net cash used in investing activities   (402,500,000)
Cash flows from financing activities:    
Proceeds from purchase of Class B shares by initial shareholder   25,000
Proceeds from initial public offering, net of underwriters' discount   394,450,000
Proceeds from private placement   10,050,000
Payment of offering costs   (595,524)
Net cash provided by financing activities   403,929,476
Net change in cash   58,873
Cash, beginning of the period   0
Cash, end of the period $ 58,873 58,873
Supplemental disclosure of cash flow information:    
Deferred underwriting commissions charged to temporary equity   $ 14,087,500